El Lilly’s (LLY) blockbuster weight-loss drug Zepbound is now eligible for Medicare coverage. The news could significantly ...

It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...

In a recent episode of the global health and wellness show Bloom, host Gayle Guyardo welcomed Dr. Bharti Shetye, MD, MFOMA, a ...

Moreno said he expects that Zepbound could be used in addition to PAP or as an alternate for people who are uncomfortable ...

Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand version between February and March 2025.

The Centers for Medicare & Medicaid Services confirmed to CNBC that Medicare drug plans can now cover Eli Lilly’s (LLY) obesity drug Zepbound for obstructive sleep apnea, reported Annika Kim ...

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...

The FDA is currently reconsidering its decision to take Zepbound off its drug shortages list following a lawsuit from a trade association representing compounding pharmacies. Removing Zepbound ...

So, Zepbound is expected to take the lead in the obesity market if it hasn’t already done so.” Based on SURMOUNT-5 results released last month, Zepbound was more effective in promoting weight ...

and perhaps negotiations with national health services will also make it more cost-effective than Wegovy,” Alciati continued.

That’s about half the cost of Zepbound’s regular list price of $1,060. But there’s a caveat: To take advantage of the savings, patients will need to pay out of pocket and administer the ...